• CONCLUSION: The prevalence of DR in Iran appears a little high. NPDR was more common. This study highlights the necessity for DR screening and management in diabetic patients in Iran.
INTRODUCTION

D
iabetic retinopathy (DR) is a major cause of visual impairment and blindness among working aged adults worldwide [1] . As the prevalence of diabetes in adults of working-age increases [2] , a parallel increase in DR as common complication of diabetes might be expected. There are two types of diabetic retinopathy: non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). NPDR, also known as background retinopathy, is the early stage of the disease in which symptoms will be mild or non-existent. PDR is the more advanced form of the DR and mainly occurs when abnormal new blood vessels grow on the surface of the retina [1, 3] . The known risk factors for DR are duration of diabetes, hyperglycemia, hypertension and dyslipidemia [1, [3] [4] . Previous research indicated that the risk of vision loss due to DR could be reduced by tight control of serum glucose and blood pressure [4] . A recent systematic review of 35 population-based studies around the world showed that the prevalence of DR and PDR among people with diabetes was 34.6% and 7.0%, respectively [5] . Moreover, both DR and PDR prevalence were higher in people with type I compared with type II diabetes [5] . Despite the importance of this issue, and its significant impact on the health care systems and the rising prevalence of diabetes notably in working-age adults, there are no overall precise estimates of the DR prevalence in Iran, particularly based on the two main type of DR (i.e. NPDR and PDR). Previous individual researches have shown considerable variability in DR prevalence estimates among adults with both type I and II diabetes, with rates ranging from 10.4% to 76.4% . Due to the considerable heterogeneity among the reported prevalence rate of DR in previous individual studies and significant impact of DR on the health-care systems, the broader and more precise estimate of the prevalence of DR is necessary for strategic plan and health policy. We therefore performed a systematic review and Meta-analysis of all published studies to estimate the overall prevalence rate of DR as well as NPDR and PDR among adult diabetic persons in Iran.
MATERIALS AND METHODS Search Strategy
This Meta-analysis was conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist [37] . We conducted a literature search of published papers in September 2016 using international and national electronic databases Web of Science, PubMed, Scopus, Google Scholar, Magiran, SID, and Iranmedex. Key words included "diabetic retinopathy", "prevalence" and "Iran". We also checked the reference lists of the included article for further relevant articles. No language or time restriction was applied to the searches.
Inclusion and Exclusion Criteria
The following inclusion criteria were used to select studies for the Meta-analysis: 1) studies with prevalence estimates of DR, 2) studies of any language and time. We excluded the following studies: [38] . For the Cochrane Q test, P<0.10 was considered statistically significant for heterogeneity. The I 2 statistic indicates the percentage of total variation across studies due to heterogeneity rather than chance. I 2 values of 25%, 50% and 75% correspond to low, moderate and high heterogeneity, respectively [38] . The Meta-analysis was performed with a random effect model, considering the remarkable heterogeneity among studies. Meta regression was conducted to explore the sources of betweenstudy heterogeneity, including year of study and sample size. We conducted sensitivity analyses by excluding each study at a time from the Meta-analysis, in order to examine its influence on the pooled estimate. The Galbraith plot was also used to detect the potential sources of heterogeneity [39] . The
Funnel plot and Begg's rank correlation and Egger's weighted regression tests were used to assess publication bias [40] [41] .
Finally, cumulative Meta-analysis was also conducted to investigate whether the magnitude of prevalence rate changes markedly with time of study. Figure 1 shows the results of the literature search and selection process based on the PRISMA flow chart for systematic reviews [37] . A total of 225 potentially relevant articles were identified from the initial searches. After removing duplicates, 112 articles remained. We excluded 69 articles by screening titles and abstracts, and retrieved the full texts of 43 remaining articles. Finally, 31 studies met the inclusion criteria and were included in this Meta-analysis ( Figure 1 ).
RESULTS
Study Selection
Study Characteristics
The characteristics of included studies are presented in Table 1 . These studies were published between 2003 (Janghorbani et al [6] ) and 2016 (Eslami et al [36] ). The sample size of included articles varied from 46 (Soleymanian et al [33] ) to 3734 (Hosseini et al [21] ), with a total of 23 729 cases. Figure 2 , the lowest and highest prevalence of DR was reported by Ghodsi et al [30] in Fasa (southern of Iran) (10.4%, 95% CI: 4.5-16.3) and FaghihImani et al [11] in Isfahan (center of Iran) (76.4%, 95% CI: 72.1- 80.7), respectively. In addition, the pooled prevalence rates of NPDR ( Figure 3 ) and PDR ( Figure 4) [11] ) and 43.01% (when excluding Ghodsi et al [30] ). And also, after sensitivity analysis, pooled prevalence [12] ) to 14.02% (when excluding Shafiepour et al [16] ) and the pooled prevalence of NPDR ranging from 31.17% (when excluding Ghasemi et al [9] ) to 32.9% (when excluding Davari et al [19] ). Cumulative Meta-analysis Cumulative Meta-analysis was also performed by sorting the studies based on publication time. As shown in Figures 8, 9 and 10, cumulative Metaanalysis of DR prevalence revealed that the overall prevalence estimates were stable and that the 95% CIs narrowed with accumulation of data over time. DISCUSSION It is very important to estimate the prevalence of DR as it is a key indicator of systemic diabetic microvascular complications, which, in turn, is a crucial indicator of the impact of diabetes on patients. Furthermore, it is adequately essential to create an extensive and more accurate estimate of the prevalence of DR, particularly for its two main type (i.e. NPDR and PDR), so it can be used for guiding public health education and managing the clinical aspects of this disease in a favorable way. The better management of DR and diabetes, and overall increased screening for diabetes, may have caused the incidence and prevalence DR to decline over time [42] . With the expected increased prevalence of type 2 diabetes in the population, in part due to increasing rates of obesity and decreasing physical activity, the burden of diabetic retinopathy might be expected to increase as well [5, 43] . However, improved access to screening tools and treatment of diabetic retinopathy may reduce the burden of diabetes-related vision loss. To the best of our knowledge, this is the first systematic review and Meta-analysis of DR prevalence in Iran. In this Metaanalysis, a total of 31 studies with 23 729 people with diabetes were included. In the present study, the overall prevalence of DR using the random effect model was 41.9%, which is higher than what was reported in United Arab Emirates (19.0%) [44] , India (21.7%) [45] , Mainland China (23.0%) [46] , Peru (23.1%) [47] , Puerto Rico (37.7%) [48] , but lower than what was reported in adult Latinos (46.9%) [49] . As indicated in the findings, there was considerable heterogeneity among included studies. Some of these differences between individual studies regarding DR prevalence, may be due to the differences in time periods of the studies. Also, in this Meta-analysis, it is possible that the prevalence rates of DR have been affected by the dissimilarity of studies concerning the ophthalmologic definitions and examination methodologies. However, the pooled prevalence rates of DR were also estimated by random-effects model. Furthermore, DR susceptibility may also vary among different ethnic groups [5] . Although the prevalence of DR in this Metaanalysis is higher than the previously reported global estimates of 34.6% reported by Yau et al [5] , several factors make it difficult to compare the estimates. The present study has several strengths that should be mentioned. The major strengths of our study were the large sample size of diabetic patients, which enabled us to estimate the overall prevalence of DR from different prevalence studies. Second, the funnel plot and the Begg and Egger's tests did not support the presence of publication bias, providing further indication of the robustness of our results. Nevertheless, our study has some limitations that should be noted when interpreting the findings. First, considerable heterogeneity was observed among studies. Therefore, even if we used random effects model to take heterogeneity into account, our overall estimates should be interpreted with caution. Second, we could not conduct Metaregression for other sources of between-study heterogeneityhyperglycemia, hypertension and dyslipidemia-since we did not have data on these risk factors. These factors have been found to be related to DR. Finally, the absence of studies from the South, South East, and North West of Iran could also affect the generalizability of our findings.
Evaluation of Heterogeneity and Meta-analysis
In Iran, the prevalence of DR, especially PDR, appeared a little high. Furthermore, with the aging of the population and the increasing prevalence of diabetes among working-aged adults, the number of individuals of DR will likely increase. Our data provide policy makers updated information for use in effective screening of DR, planning eye care services, management of DR risk factors and rehabilitation.
